These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
61 related articles for article (PubMed ID: 16398367)
1. [Cloning and expression of androgen response elements of prostate specific antigen promoter]. Hu Y; Shang XJ; Ge JP; Sun Y; Huang YF Zhonghua Nan Ke Xue; 2005 Dec; 11(12):930-2. PubMed ID: 16398367 [TBL] [Abstract][Full Text] [Related]
2. Identification of a positive regulatory element responsible for tissue-specific expression of prostate-specific antigen. Pang S; Dannull J; Kaboo R; Xie Y; Tso CL; Michel K; deKernion JB; Belldegrun AS Cancer Res; 1997 Feb; 57(3):495-9. PubMed ID: 9012480 [TBL] [Abstract][Full Text] [Related]
3. A G/A polymorphism in the androgen response element 1 of prostate-specific antigen gene correlates with the response to androgen deprivation therapy in Japanese population. Shibahara T; Onishi T; Franco OE; Arima K; Nishikawa K; Yanagawa M; Hioki T; Watanabe M; Hirokawa Y; Shiraishi T; Sugimura Y Anticancer Res; 2006; 26(5A):3365-71. PubMed ID: 17094454 [TBL] [Abstract][Full Text] [Related]
4. Prostate-specific targeting using PSA promoter-based lentiviral vectors. Yu D; Chen D; Chiu C; Razmazma B; Chow YH; Pang S Cancer Gene Ther; 2001 Sep; 8(9):628-35. PubMed ID: 11593331 [TBL] [Abstract][Full Text] [Related]
5. Use of the PSA enhancer core element to modulate the expression of prostate- and non-prostate-specific basal promoters in a lentiviral vector context. Chapel-Fernandes S; Jordier F; Lauro F; Maitland N; Chiaroni J; de Micco P; Mannoni P; Bagnis C Cancer Gene Ther; 2006 Oct; 13(10):919-29. PubMed ID: 16741521 [TBL] [Abstract][Full Text] [Related]
7. Prostate-tumor targeting of gene expression by lentiviral vectors containing elements of the probasin promoter. Yu D; Jia WW; Gleave ME; Nelson CC; Rennie PS Prostate; 2004 Jun; 59(4):370-82. PubMed ID: 15065085 [TBL] [Abstract][Full Text] [Related]
8. [Constructing recombinant plasmid with prostate-specific membrane antigen promoter and reverse enhancer and comparing the transcription activity of enhancers in different directions]. Zeng H; Liao YC; Wang F; Wu Q; Yang YR Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 Nov; 36(6):782-5. PubMed ID: 16334552 [TBL] [Abstract][Full Text] [Related]
9. Identification and characterization of the novel human prostate cancer-specific PC-1 gene promoter. Wang J; Zhang H; Liang RX; Pang B; Shi QG; Huang PT; Huang CF; Zhou JG Biochem Biophys Res Commun; 2007 May; 357(1):8-13. PubMed ID: 17418805 [TBL] [Abstract][Full Text] [Related]
10. Androgen-dependent gene expression of prostate-specific antigen is enhanced synergistically by hypoxia in human prostate cancer cells. Horii K; Suzuki Y; Kondo Y; Akimoto M; Nishimura T; Yamabe Y; Sakaue M; Sano T; Kitagawa T; Himeno S; Imura N; Hara S Mol Cancer Res; 2007 Apr; 5(4):383-91. PubMed ID: 17426252 [TBL] [Abstract][Full Text] [Related]
11. Gene silencing in androgen-responsive prostate cancer cells from the tissue-specific prostate-specific antigen promoter. Song J; Pang S; Lu Y; Yokoyama KK; Zheng JY; Chiu R Cancer Res; 2004 Nov; 64(21):7661-3. PubMed ID: 15520164 [TBL] [Abstract][Full Text] [Related]
12. [Construction of a plasmid vector of fused protein genes driven by human insulin-like growth factor II P3 promoter]. Zhou HK; Yang DH; Tang SH; Huang W; Lu XH Zhonghua Yi Xue Za Zhi; 2006 Jan; 86(2):106-10. PubMed ID: 16620715 [TBL] [Abstract][Full Text] [Related]
13. Identification and characterization of regulatory elements of the human prostatic acid phosphatase promoter. Zelivianski S; Igawa T; Lim S; Taylor R; Lin MF Oncogene; 2002 May; 21(23):3696-705. PubMed ID: 12032838 [TBL] [Abstract][Full Text] [Related]
14. Robust prostate-specific expression for targeted gene therapy based on the human kallikrein 2 promoter. Xie X; Zhao X; Liu Y; Young CY; Tindall DJ; Slawin KM; Spencer DM Hum Gene Ther; 2001 Mar; 12(5):549-61. PubMed ID: 11268287 [TBL] [Abstract][Full Text] [Related]
15. An AKT activity threshold regulates androgen-dependent and androgen-independent PSA expression in prostate cancer cell lines. Paliouras M; Diamandis EP Biol Chem; 2008 Jun; 389(6):773-80. PubMed ID: 18627304 [TBL] [Abstract][Full Text] [Related]
16. Prosaposin upregulates AR and PSA expression and activity in prostate cancer cells (LNCaP). Koochekpour S; Lee TJ; Wang R; Culig Z; Delorme N; Caffey S; Marrero L; Aguirre J Prostate; 2007 Feb; 67(2):178-89. PubMed ID: 17044040 [TBL] [Abstract][Full Text] [Related]
17. Curcumin blocks the activation of androgen and interlukin-6 on prostate-specific antigen expression in human prostatic carcinoma cells. Tsui KH; Feng TH; Lin CM; Chang PL; Juang HH J Androl; 2008; 29(6):661-8. PubMed ID: 18676361 [TBL] [Abstract][Full Text] [Related]
18. Regulation of prostate-specific antigen expression by the junctional adhesion molecule A. Wang Q; Zheng JY; Kreth J; Yan X; Kamata M; Campbell RA; Xie Y; Chiu R; Berenson JR; Shi W; Chen IS; Pang S Urology; 2009 May; 73(5):1119-25. PubMed ID: 18602143 [TBL] [Abstract][Full Text] [Related]
19. Expression of the forkhead transcription factor FOXP1 is associated both with hypoxia inducible factors (HIFs) and the androgen receptor in prostate cancer but is not directly regulated by androgens or hypoxia. Banham AH; Boddy J; Launchbury R; Han C; Turley H; Malone PR; Harris AL; Fox SB Prostate; 2007 Jul; 67(10):1091-8. PubMed ID: 17477366 [TBL] [Abstract][Full Text] [Related]
20. ARE-I polymorphism on PSA gene in prostate cancer patients of a Turkish population. Kalay E; Ergen A; Narter F; Agaçhan B; Görmüs U; Yigit N; Isbir T Anticancer Res; 2009 Apr; 29(4):1395-8. PubMed ID: 19414393 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]